Oxford Cancer Analytics
OXcan
Oxford, United Kingdom · Founded 2020
- Headquarters
- Oxford
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- oxcan.org
- Last Round
- Series AJan 2025
- Rounds
- 2
About
Enabling Curative Cancer Treatment Through Early Detection- Focused on Lung Cancer
Summary
Oxford Cancer Analytics is a Healthcare company based in Oxford, United Kingdom, founded in 2020. Its most recent funding was a Series A round in Jan 2025. Investors include Eka Ventures, Cross-Border Impact Ventures and We Ventures.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2025
Sign up to see all 2 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/oxford-cancer-analytics"><img src="https://indexed.vc/api/badge/company/oxford-cancer-analytics" alt="Oxford Cancer Analytics on Indexed.vc" width="260" height="76" /></a>